title: [Moderate asthma in adults: diagnosis and management in general medical practice].
abstract: Moderate asthma is a frequent disorder in general medicine. In 1990, the British Thoracic Society published their first guidelines on the management of asthma. Three years later, we have studied, using a questionnaire, the diagnosis and therapeutic criteria of moderate asthma used by general physicians, and comparing these to the guideline recommendations. Out of 46 physicians questioned in Bordeaux, 40 (87 per cent) agreed to participate in the study. Thirty two physicians (80 per cent) described as moderate an asthma which was mild according to the guidelines; eight physicians (20 per cent) described a moderate asthma according to the guidelines; twenty five (63 per cent) considered as severe a moderate asthma according to the recommendations, although eleven (28 per cent) considered it as moderate and four (10 per cent) did not give an opinion. In total, four (10 per cent) judged asthma severity according to the guidelines (Group R), twenty one (52 per cent) over-estimated the severity of moderate asthma (Group S), and fifteen (37 per cent) gave an inconsistent assessment (Group 1). Twenty six (65 per cent) prescribed an association of beta-2-agonists and inhaled corticosteroids for moderate asthma. Although most of the questioned physicians gave an appropriate treatment for moderate asthma treatment adapted to the severity of the situation, their therapeutic approach did not seem to be based upon the same criteria than that recommended in the guidelines.
authors.affiliation: Service des Maladies Respiratoires, Hôpital du Haut-Lévêque, CHU de Bordeaux, Pessac.
authors.forename: J M
authors.initials: JM
authors.lastname: Vernejoux
authors.forename: J M
authors.initials: JM
authors.lastname: Tunon De Lara
authors.forename: A V
authors.initials: AV
authors.lastname: Guizard
authors.forename: P
authors.initials: P
authors.lastname: Villanueva
authors.forename: A
authors.initials: A
authors.lastname: Taytard
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy*; D001291:Attitude of Health Personnel; D005194:Family Practice; D005500:Follow-Up Studies; D005602:France; D017408:Guidelines as Topic; D006801:Humans; D013224:Status Asthmaticus / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy; D011795:Surveys and Questionnaires
chemical_list: D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents